The DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index; 21 of the 41 sources its claims cite were checked for support.
Diagnostic Yield and Clinical Implications of Implantable Loop Recorders in Patients with Syncope in Germany: A National Database Analysis
Open accessAbstract
In patients with unexplained syncope, implantable loop recorders (ILR) are used to detect arrhythmias as a cause of syncope. This study aimed to assess the diagnostic yield and clinical implications arising from ILR implantation in patients with syncope in Germany. Secondary longitudinal data were obtained from a large German research database including anonymized data from nationwide statutory health insurances, representative for the German population. Patients ≥ 18 years with a diagnosis of syncope and ILR implantation between 2017 and 2018 were analyzed, and cardiac diagnoses and therapies during a follow-up period of two years assessed. Of 2,403,301 continuously insured persons in 2017-2018, 1360 (0.1%) received an ILR and 675 patients (45.6% female) were included. During follow-up, arrhythmias were diagnosed in 65.0%. The following antiarrhythmic therapies were established: pacemaker and defibrillator implantations in 20% and 1.5%, respectively, ablation therapy in 3.0%, and antiarrhythmic drug therapy in 4.7%. Aside from the diagnoses typically associated with syncope, atrial fibrillation or flutter was diagnosed in 37.0%, and anticoagulation therapy was initiated in 21.5%. There was a high diagnostic yield of arrhythmias following ILR implantation, leading to a relevant number of syncope-specific treatment. Arrhythmias not necessarily related to syncope were also diagnosed, leading to a high rate of anticoagulation therapy.
Overview
CoChat Summary
## TL;DR
This retrospective national database study found that implantable loop recorders (ILRs) in German patients with syncope had a high two-year diagnostic yield, with arrhythmias detected in 65.0% of patients. The findings also showed substantial downstream treatment changes, including pacemaker implantation in 20.0% and initiation of anticoagulation in 21.5%.
## Key findings
- Of 2,403,301 continuously insured persons, 1,360 (0.06% in the results text; 0.1% in the abstract) received an ILR in 2017–2018, and 675 patients with syncope were included in the analysis.
- During 2 years of follow-up, arrhythmias were diagnosed in 65.0% of patients; 37.0% were diagnosed with atrial fibrillation or flutter.
- 23.6% underwent at least one interventional therapy: 20.0% received a pacemaker, 1.5% a defibrillator, and 3.0% ablation therapy.
- 24.7% started drug therapy: 21.5% were started on anticoagulation and 4.7% on antiarrhythmic medication.
## Methods
- Observational retrospective longitudinal secondary-data analysis using the WIG2 research database of anonymized German statutory health insurance claims; the database is described as representative for the German population by age and gender.
- Included adults ≥18 years with syncope (ICD-10-GM R55) and ILR implantation (OPS 5-377.8) between 2017 and 2018, with continuous insurance for 24 months after the index day; excluded patients with prior stroke, ablation, prior ILR-related procedures, or cardiac electronic devices in 2016.
- Main analyses were descriptive: counts, percentages, mean, and SD; outcomes included ILR-related cardiac diagnoses, time to diagnosis, and initiation/time to therapies identified via ICD-10-GM, OPS, and ATC codes.
## Limitations
- The paper states that billing-based ICD-10-GM/OPS coding may have led to over- and under-diagnosis, and that grouped ICD-10-GM codes did not allow detailed diagnostic analysis.
- The paper states that R55 includes syncope and collapse, which may have included some patients without actual syncope, though it argues this was likely limited because reimbursement requires evidence of indication beyond ICD coding.
- The paper states that there were no detailed data on pre-ILR diagnostic workup and only 2 years of follow-up, with no further follow-up beyond certain therapies, so other relevant findings may have been missed.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
9 Valid · 0 Not valid · 5 Not checked · 33 Own results and interpretations
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Holter monitoring and external loop recorders serve as main noninvasive monitoring strategies, but the diagnostic yield is low, especially in cases of infrequent symptoms [5,7].”
§ Diagnostic Yield and Clinical Implications of Implantable Loop Recorders in Patients with Syncope in Germany: A National Database Analysis > 1. Introduction Syncope is a common clinical issue with an approximate incidence of 6.2 per 1000 person-years and is associated with increased morbidity and mortality including sudden cardiac death for patients suffering from cardiac or unexplained syncope [1]. Establishment of a diagnosis is crucial for adequate treatment and prevention of future events [2,3,4,5]. However, the cause of syncope remains unknown in up to one third of patients [5,6]. As cardiac arrhythmias can be a cause for unexplained syncope, close rhythm monitoring is crucial. Holter monitoring and external loop recorders serve as main noninvasive monitoring strategies, but the diagnostic yield is low, especially in cases of infrequent symptoms [5,7]. Digital mobile or wearable devices are also increasingly used in the detection of arrhythmias [8,9,10]. However, recordings usually require patient activation at the time of symptoms. The use of such devices in the context of syncope is, therefore, limited. Moreover, reimbursement in daily clinical practice is lacking [11]. Next to noninvasive monitoring strategies, implantable loop recorders (ILR) are used to confirm the etiology of syncope [2,12,13,14,15,16,17,18], with a shorter time to diagnosis, more frequent treatment initiation, and a positive impact on survival compared to a conventional diagnostic workup [13,17,19]. These devices were first introduced in the 1990s [20] and have since been improved and miniaturized. They are inserted subcutaneously in the left pectoral region under local anesthesia, and they allow long-term continuous single-lead ECG monitoring. The availability of remote monitoring has further improved the diagnostic timing and follow-up with a potential economization of health care resources. The application of different ECG technologies in the workup of patients with syncope seems to be similar among Western countries [21]. While international guidelines recommend ILR implantation in patients with unexplained recurrent syncope after a standard workup [5,22,23,24], implementation in daily clinical practice is lagging behind, partly due to reimbursement issues [25,26,27,28,29,30]. In Germany, ILR implantation in the outpatients’ sector is usually associated with a high bureaucratic effort that includes writing individual reimbursement requests to health insurances attesting a proper diagnostic workup and indication according to guidelines [31]. Data on the diagnostic yield as well as clinical implications arising from ILR implantation following syncope in a real-world setting of the German population are scarce. The aim of this study was, therefore, to address this question, acquiring and analyzing national representative real-world data on current ILR implantations including follow-up data in Germany.
What the sources say
- Supportedcites [5] Brignole, 2018, 2018 ESC Guidelines for the Diagnosis and Management of Syncope, Eur. Heart J. source
The Holter monitoring section (p. 23) says its diagnostic yield in unselected patients with syncope may be as low as 1–2% because symptoms often do not recur during monitoring. The external loop recorder section (p. 24) reports a 24.5% yield and says these recorders are useful when episodes are relatively frequent; the recommendations (p. 25) likewise limit their use to shorter inter-symptom intervals. Together, these passages support the point that diagnostic yield is limited, particularly when symptoms are infrequent, while noting that external loop recorders yield more diagnoses than Holter monitoring. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [7] Bass, 1990, The Duration of Holter Monitoring in Patients with Syncope. Is 24 Hours Enough?, Arch. Intern. Med. source
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“However, the cause of syncope remains unknown in up to one third of patients [5,6].”
§ Diagnostic Yield and Clinical Implications of Implantable Loop Recorders in Patients with Syncope in Germany: A National Database Analysis > 1. Introduction Syncope is a common clinical issue with an approximate incidence of 6.2 per 1000 person-years and is associated with increased morbidity and mortality including sudden cardiac death for patients suffering from cardiac or unexplained syncope [1]. Establishment of a diagnosis is crucial for adequate treatment and prevention of future events [2,3,4,5]. However, the cause of syncope remains unknown in up to one third of patients [5,6]. As cardiac arrhythmias can be a cause for unexplained syncope, close rhythm monitoring is crucial. Holter monitoring and external loop recorders serve as main noninvasive monitoring strategies, but the diagnostic yield is low, especially in cases of infrequent symptoms [5,7]. Digital mobile or wearable devices are also increasingly used in the detection of arrhythmias [8,9,10]. However, recordings usually require patient activation at the time of symptoms. The use of such devices in the context of syncope is, therefore, limited. Moreover, reimbursement in daily clinical practice is lacking [11]. Next to noninvasive monitoring strategies, implantable loop recorders (ILR) are used to confirm the etiology of syncope [2,12,13,14,15,16,17,18], with a shorter time to diagnosis, more frequent treatment initiation, and a positive impact on survival compared to a conventional diagnostic workup [13,17,19]. These devices were first introduced in the 1990s [20] and have since been improved and miniaturized. They are inserted subcutaneously in the left pectoral region under local anesthesia, and they allow long-term continuous single-lead ECG monitoring. The availability of remote monitoring has further improved the diagnostic timing and follow-up with a potential economization of health care resources. The application of different ECG technologies in the workup of patients with syncope seems to be similar among Western countries [21]. While international guidelines recommend ILR implantation in patients with unexplained recurrent syncope after a standard workup [5,22,23,24], implementation in daily clinical practice is lagging behind, partly due to reimbursement issues [25,26,27,28,29,30]. In Germany, ILR implantation in the outpatients’ sector is usually associated with a high bureaucratic effort that includes writing individual reimbursement requests to health insurances attesting a proper diagnostic workup and indication according to guidelines [31]. Data on the diagnostic yield as well as clinical implications arising from ILR implantation following syncope in a real-world setting of the German population are scarce. The aim of this study was, therefore, to address this question, acquiring and analyzing national representative real-world data on current ILR implantations including follow-up data in Germany.
What the sources say
- Partly supportedcites [5] Brignole, 2018, 2018 ESC Guidelines for the Diagnosis and Management of Syncope, Eur. Heart J. sourceExperimental — accuracy not yet measured
The guidelines recognize that a cause may remain unidentified: Additional advice and clinical perspectives (p. 13) says the initial evaluation can be unable to suggest any diagnosis. They do not establish that this occurs in up to one third of patients. The 30–36% figures on p. 22 are tilt-test positivity rates among patients with unexplained syncope, not the proportion of all patients whose cause remains unknown. (LLM, conf=0.82)
- Supportedcites [6] Reed, 2013, Incidence, Etiology and Predictors of Adverse Outcomes in 43,315 Patients Presenting to the Emergency Department with Syncope: An International Meta-Analysis, Int. J. Cardiol. source
The Discussion states that the etiology of syncope was unclear in one third of cases in this study. The pooled-results passage also reports that 29% of patients were discharged without a diagnosis, consistent with the citing sentence’s approximate figure. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Most patients receiving an ILR within this population had a diagnosis of syncope (53.9%), which is in line with previous data from an international ILR registry [35].”
- Also stated in: § 3.1. Study Population and Baseline Characteristics · plain
“733 (53.9%) had a diagnosis of syncope.”
§ Diagnostic Yield and Clinical Implications of Implantable Loop Recorders in Patients with Syncope in Germany: A National Database Analysis > 4. Discussion
What the sources say
- Supportedcites [35] Lau, 2023, Diagnostic Yield of an Insertable Cardiac Monitor in a Large Patient Population, Heart Rhythm. O2 source
The citation supports the comparison with previous registry data, not the citing population’s 53.9% figure. In Results > Patients, the source reports that syncope was the ICM indication for 60.8% of its patients; the Discussion likewise describes this as most patients (approximately 61%). (LLM, conf=0.91)
plainn = 58- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.1. Study Population and Baseline Characteristics · plain
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Hence, the ILR provided a high diagnostic yield in terms of cardiac arrhythmias in patients with syncope, not restricted to arrhythmias directly related to syncope [12,13,14,15,17,19,35,36] but including other diagnoses with therapeutic implications such as atrial fibrillation.”
§ Diagnostic Yield and Clinical Implications of Implantable Loop Recorders in Patients with Syncope in Germany: A National Database Analysis > 4. Discussion > 4.1. Diagnostic Yield after ILR Implantation
What the sources say
- Partly supportedcites [12] Lombardi, 2005, Utility of Implantable Loop Recorder (Reveal Plus®) in the Diagnosis of Unexplained Syncope, Europace sourceExperimental — accuracy not yet measured
The Pre-syncopal events section reports that ILR monitoring detected a rhythm disturbance in 13 patients and achieved a diagnosis in 18 of 20 patients with syncopal or pre-syncopal events, supporting a high diagnostic yield in patients with recurrences. The reported arrhythmias are tied to those events; our copy does not establish a high yield for arrhythmias unrelated to syncope or pre-syncope. The Syncopal episodes section records atrial fibrillation during a syncopal episode, not as an unrelated finding. Page numbers are unavailable in our copy. (LLM, conf=0.84)
- Partly supportedcites [13] Edvardsson, 2011, Use of an Implantable Loop Recorder to Increase the Diagnostic Yield in Unexplained Syncope: Results from the PICTURE Registry, Europace sourceExperimental — accuracy not yet measured
The Results (Specific treatment based on diagnosis made by ILR; page not provided) report that 128 of 170 ILR-guided diagnoses were cardiac, supporting a high cardiac diagnostic yield. But the paper assesses diagnoses associated with recurrent syncope; the cited passages do not establish a yield for arrhythmias unrelated to syncope or for atrial fibrillation specifically. (LLM, conf=0.87)
- Not checked — no full text of the sourcecites [14] Krahn, 2001, Randomized Assessment of Syncope Trial, Circulation source
- Supportedcites [15] Costa, 2013, Clinical Impact of the Implantable Loop Recorder in Patients with Isolated Syncope, Bundle Branch Block and Negative Workup: A Randomized Multicentre Prospective Study, Arch. Cardiovasc. Dis. source
The Major findings section reports that ILR detected arrhythmic events in 36.6% of patients with a first syncope episode, bundle branch block, and a negative electrophysiological study. The Endpoints section explicitly includes significant asymptomatic arrhythmias, so detection was not limited to arrhythmias recorded during syncope. The cited study supports this claim for its specific patient population. (LLM, conf=0.89)
- Partly supportedcites [17] Sulke, 2016, The Benefit of a Remotely Monitored Implantable Loop Recorder as a First Line Investigation in Unexplained Syncope: The EaSyAS II Trial, Europace sourceExperimental — accuracy not yet measured
The Primary outcome section (page unavailable) reports an ECG diagnosis in 50% of ILR recipients, and the Remotely monitored implantable loop recorder section reports a bradycardia pacing indication in 22%. These findings support substantial diagnostic yield in patients with unexplained syncope, but the paper does not establish that the arrhythmias detected were unrelated to syncopal events. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [19] Perings, 2021, Do Implantable Loop Recorders Impact the Survival of Patients with Recurrent Unexplained Syncope?, J. Comp. Eff. Res. source
- Supportedcites [35] Lau, 2023, Diagnostic Yield of an Insertable Cardiac Monitor in a Large Patient Population, Heart Rhythm. O2 source
The Results (Diagnoses; page not provided) report a 34.2% estimated diagnostic yield at one year among patients monitored for syncope. They also report AF detected in 26 of these patients (6.8%), who received treatment, supporting the point that useful diagnoses were not limited to arrhythmias directly linked to syncope. (LLM, conf=0.93)
- Supportedcites [36] Lee, 2019, Usefulness of an Implantable Loop Recorder in Diagnosing Unexplained Syncope and Predictors for Pacemaker Implantation, J. Korean Med. Sci. source
The Results section reports significant arrhythmia detected by ILR irrespective of syncope in 99 of 173 patients (57.2%). The Discussion contrasts that finding with symptom-correlated ECG diagnoses in 34 patients (19.6%), supporting the claim that diagnostic yield was not limited to arrhythmias recorded during syncope. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“antiarrhythmic drug therapy in 4.7%”
- Also stated in: § 3.2. Follow-Up · plain
“32 patients (4.7%) were started on antiarrhythmic medication”
- Also stated in: § 4.2. Therapeutic Implications · plain
“antiarrhythmic medication (4.7%)”
§ Diagnostic Yield and Clinical Implications of Implantable Loop Recorders in Patients with Syncope in Germany: A National Database Analysis > Abstract
plainn = 32- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § 3.2. Follow-Up · plain
26 more claims
Create a free account to see all 47 claims and to verify the 3 references still open.
- Probably not a substantial claim. 10
- It may state two separate claims as one. 6
- The quote only partly states this claim. 1
Citations
Cites
2018 ESC Guidelines for the diagnosis and management of syncope
Brignole, M., Moya, A., de Lange, F. J., Deharo, J.-C., Elliott, P. M., Fanciulli, A., Fedorowski, A., Furlan, R., Kenny, R. A., Martín, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy037 · Cited by 1,951
Incidence and Prognosis of Syncope
Soteriades, E. S., Evans, J. C., Larson, M. G., Chen, M. H., Chen, L., Benjamin, E. J., & Levy, D. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012407 · Cited by 1,364 · cited 1×
“Syncope is a common clinical issue with an approximate incidence of 6.2 per 1000 person-years and is associated with increased morbidity and mortality including sudden cardiac death for patients suffering from cardiac or unexplained syncope [1].”
BackgroundInfluentialSvendsen, J. H., Diederichsen, S. Z., Højberg, S., Krieger, D. W., Graff, C., Kronborg, C., Olesen, M. S., Nielsen, J. B., Holst, A. G., Brandes, A., et al. (2021) · The Lancet · doi:10.1016/s0140-6736(21)01698-6 · Cited by 550 · cited 1×
“Establishment of diagnoses lead to therapeutic consequences in many cases, including not only the implantation of a pacemaker or defibrillator, but also other treatments such as the beginning of anticoagulation therapy in a relevant number of patients.”
BackgroundEvaluation and Outcome of Patients with Syncope
KAPOOR, W. N. (1990) · Medicine · doi:10.1097/00005792-199005000-00004 · Cited by 539 · cited 1×
“These devices were first introduced in the 1990s [20] and have since been improved and miniaturized.”
Background2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Heart Rhythm · doi:10.1016/j.hrthm.2017.03.004 · Cited by 478
Gute Praxis Sekundärdatenanalyse (GPS): Leitlinien und Empfehlungen
Swart, E., Gothe, H., Geyer, S., Jaunzeme, J., Maier, B., Grobe, T., & Ihle, P. (2015) · Das Gesundheitswesen · doi:10.1055/s-0034-1396815 · Cited by 445 · cited 1×
“The study was conducted following the guideline of “Good Practice Secondary Data” [32].”
MethodShen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000499 · Cited by 438
Brignole, M., Menozzi, C., Moya, A., Andresen, D., Blanc, J. J., Krahn, A. D., Wieling, W., Beiras, X., Deharo, J. C., Russo, V., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.082313 · Cited by 437
Shen, W.-K., Sheldon, R. S., Benditt, D. G., Cohen, M. I., Forman, D. E., Goldberger, Z. D., Grubb, B. P., Hamdan, M. H., Krahn, A. D., Link, M. S., et al. (2017) · Circulation · doi:10.1161/cir.0000000000000498 · Cited by 407
Krahn, A. D., Klein, G. J., Yee, R., & Skanes, A. C. (2001) · Circulation · doi:10.1161/01.cir.104.1.46 · Cited by 405
How to use digital devices to detect and manage arrhythmias: an EHRA practical guide
Svennberg, E., Tjong, F., Goette, A., Akoum, N., Di Biase, L., Bordachar, P., Boriani, G., Burri, H., Conte, G., Deharo, J. C., et al. (2022) · Europace · doi:10.1093/europace/euac038 · Cited by 261 · cited 1×
“Digital mobile or wearable devices are also increasingly used in the detection of arrhythmias [8–10].”
MethodSelf-citationEdvardsson, N., Frykman, V., van Mechelen, R., Mitro, P., Mohii-Oskarsson, A., Pasquie, J.-L., Ramanna, H., Schwertfeger, F., Ventura, R., Voulgaraki, D., et al. (2011) · Europace · doi:10.1093/europace/euq418 · Cited by 250 · cited 2×
“Establishment of diagnoses lead to therapeutic consequences in many cases, including not only the implantation of a pacemaker or defibrillator, but also other treatments such as the beginning of anticoagulation therapy in a relevant number of patients.”
BackgroundMethodThe clinical impact of implantable loop recorders in patients with syncope
Farwell, D. J., Freemantle, N., & Sulke, N. (2006) · European Heart Journal · doi:10.1093/eurheartj/ehi602 · Cited by 219
Characteristics and external validity of the German Health Risk Institute (HRI) Database
Andersohn, F., & Walker, J. (2016) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3895 · Cited by 197 · cited 1×
“The WIG2 research database provides data representative of the German population with respect to age and gender distribution and includes anonymized data on the healthcare use and resource consumption of 4.5 million member records from nationwide statutory health insurances (SHIs) [33,34].”
InfluentialBuck, B. H., Hill, M. D., Quinn, F. R., Butcher, K. S., Menon, B. K., Gulamhusein, S., Siddiqui, M., Coutts, S. B., Jeerakathil, T., Smith, E. E., et al. (2021) · JAMA · doi:10.1001/jama.2021.6128 · Cited by 179
Schnabel, R. B., Marinelli, E. A., Arbelo, E., Boriani, G., Boveda, S., Buckley, C. M., Camm, A. J., Casadei, B., Chua, W., Dagres, N., et al. (2023) · EP Europace · doi:10.1093/europace/euac062 · Cited by 179 · cited 1×
“Establishment of diagnoses lead to therapeutic consequences in many cases, including not only the implantation of a pacemaker or defibrillator, but also other treatments such as the beginning of anticoagulation therapy in a relevant number of patients.”
BackgroundSelf-citationThe Duration of Holter Monitoring in Patients With Syncope: Is 24 Hours Enough?
Bass, E. B. (1990) · Archives of Internal Medicine · doi:10.1001/archinte.1990.00390170103022 · Cited by 156 · cited 1×
“Holter monitoring and external loop recorders serve as main noninvasive monitoring strategies, but the diagnostic yield is low, especially in cases of infrequent symptoms [5,7].”
BackgroundD'Ascenzo, F., Biondi-Zoccai, G., Reed, M. J., Gabayan, G. Z., Suzuki, M., Costantino, G., Furlan, R., Del Rosso, A., Sarasin, F. P., Sun, B. C., et al. (2013) · International Journal of Cardiology · doi:10.1016/j.ijcard.2011.11.083 · Cited by 107 · cited 1×
“However, the cause of syncope remains unknown in up to one third of patients [5,6].”
BackgroundSulke, N., Sugihara, C., Hong, P., Patel, N., & Freemantle, N. (2016) · Europace · doi:10.1093/europace/euv228 · Cited by 95 · cited 2×
“Formally, the ICD-10-GM code R55 includes syncope as well as collapse, which may have led to the inclusion of patients without actual syncope.”
BackgroundMethodPodoleanu, C., DaCosta, A., Defaye, P., Taieb, J., Galley, D., Bru, P., Maury, P., Mabo, P., Boveda, S., Cellarier, G., et al. (2014) · Archives of Cardiovascular Diseases · doi:10.1016/j.acvd.2014.05.009 · Cited by 93
ACC/AHA/HRS Versus ESC Guidelines for the Diagnosis and Management of Syncope
Goldberger, Z. D., Petek, B. J., Brignole, M., Shen, W.-K., Sheldon, R. S., Solbiati, M., Deharo, J.-C., Moya, A., & Hamdan, M. H. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2019.09.012 · Cited by 82
Brignole, M., Ammirati, F., Arabia, F., Quartieri, F., Tomaino, M., Ungar, A., Lunati, M., Russo, V., Del Rosso, A., & Gaggioli, G. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv069 · Cited by 80
Utility of Implantable Loop Recorder (Reveal Plus®) in the Diagnosis of Unexplained Syncope
LOMBARDI, F., CALOSSO, E., MASCIOLI, G., MARANGONI, E., DONATO, A., ROSSI, S., PALA, M., FOTI, F., & LUNATI, M. (2005) · Europace · doi:10.1016/j.eupc.2004.09.003 · Cited by 76 · cited 2×
“Formally, the ICD-10-GM code R55 includes syncope as well as collapse, which may have led to the inclusion of patients without actual syncope.”
BackgroundMethodSvennberg, E., Caiani, E. G., Bruining, N., Desteghe, L., Han, J. K., Narayan, S. M., Rademakers, F. E., Sanders, P., & Duncker, D. (2023) · EP Europace · doi:10.1093/europace/euad176 · Cited by 73
Self-citationDa Costa, A., Defaye, P., Romeyer-Bouchard, C., Roche, F., Dauphinot, V., Deharo, J.-C., Jacon, P., Lamaison, D., Bathélemy, J.-C., Isaaz, K., et al. (2013) · Archives of Cardiovascular Diseases · doi:10.1016/j.acvd.2012.12.002 · Cited by 63 · cited 1×
“Formally, the ICD-10-GM code R55 includes syncope as well as collapse, which may have led to the inclusion of patients without actual syncope.”
BackgroundBoriani, G., Burri, H., Svennberg, E., Imberti, J. F., Merino, J. L., & Leclercq, C. (2022) · EP Europace · doi:10.1093/europace/euac118 · Cited by 51
Boriani, G., Svennberg, E., Guerra, F., Linz, D., Casado-Arroyo, R., Małaczyńska-Rajpold, K., Duncker, D., Bovéda, S., Merino, J. L., & Leclercq, C. (2022) · EP Europace · doi:10.1093/europace/euac142 · Cited by 41 · cited 1×
“Moreover, reimbursement in daily clinical practice is lacking [11].”
BackgroundSelf-citationSciaraffia, E., Chen, J., Hocini, M., Larsen, T. B., Potpara, T., & Blomstrom-Lundqvist, C. (2014) · Europace · doi:10.1093/europace/euu222 · Cited by 33
Ko, D., Dai, Q., Flynn, D., Bosch, N. A., Helm, R. H., Monahan, K. M., Andersson, C., Anderson, C. D., & Walkey, A. J. (2021) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.09.013 · Cited by 32
Milstein, N. S., Musat, D. L., Allred, J. D., Seiler, A. K., Pimienta, J., Oliveros, S., Bhatt, A. G., Preminger, M. W., Sichrovsky, T., Shaw, R. E., et al. (2019) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-019-00628-6 · Cited by 28
Boriani, G., Imberti, J. F., Leyva, F., Casado-Arroyo, R., Chun, J., Braunschweig, F., Zylla, M. M., Duncker, D., Farkowski, M. M., Pürerfellner, H., et al. (2023) · Europace · doi:10.1093/europace/euad297 · Cited by 26
Self-citationDan, G.-A., Scherr, D., Jubele, K., Farkowski, M. M., Iliodromitis, K., Conte, G., Jędrzejczyk-Patej, E., Vitali-Serdoz, L., & Potpara, T. S. (2020) · EP Europace · doi:10.1093/europace/euaa085 · Cited by 20 · cited 1×
“While international guidelines recommend ILR implantation in patients with unexplained recurrent syncope after a standard workup [5,22–24], implementation in daily clinical practice is lagging behind, partly due to reimbursement issues [25–30].”
BackgroundLee, S. H., Kim, T.-H., Oh, Y.-S., Oh, S., Choi, J.-I., Kim, J.-B., Nah, J.-C., Im, S. I., Kang, K.-W., Han, S., et al. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e11 · Cited by 16
Boriani, G., Auricchio, A., Botto, G. L., Joseph, J., Roberts, G. J., Grammatico, A., Nabutovsky, Y., & Piccini, J. P. (2023) · EP Europace · doi:10.1093/europace/euad212 · Cited by 14
Diagnostic Yield of an Insertable Cardiac Monitor in a Large Patient Population
Lau, D. H., Pierre, B., Cabanas, P., Martens, E., Bisignani, G., Hofer, D., Berruezo, A., Eschalier, R., Mansourati, J., Gaspar, T., et al. (2023) · Heart Rhythm O2 · doi:10.1016/j.hroo.2022.11.005 · Cited by 13 · cited 2×
“Formally, the ICD-10-GM code R55 includes syncope as well as collapse, which may have led to the inclusion of patients without actual syncope.”
BackgroundMethodInfluentialAtrial fibrillation in elderly patients with implantable loop recorders for unexplained syncope
Arcinas, L. A., McIntyre, W. F., Hayes, C. J., Ibrahim, O., Baranchuk, A. M., & Seifer, C. M. (2019) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.12630 · Cited by 12
Do Implantable Loop Recorders Impact the Survival of Patients with Recurrent Unexplained Syncope?
Perings, C., Wolff, C., Wilk, A., Witthohn, A., Voss, R., & Rybak, K. (2021) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2020-0242 · Cited by 7 · cited 4×
“Formally, the ICD-10-GM code R55 includes syncope as well as collapse, which may have led to the inclusion of patients without actual syncope.”
BackgroundMethodInfluentialAltinsoy, M., Sutton, R., Kohno, R., Sakaguchi, S., Mears, R. K., & Benditt, D. G. (2021) · Journal of Arrhythmia · doi:10.1002/joa3.12560 · Cited by 7 · cited 1×
“The application of different ECG technologies in the workup of patients with syncope seems to be similar among Western countries [21].”
BackgroundKommata, V., Deharo, J.-C., Drossart, I., Foldager, D., Svennberg, E., Vernooy, K., Verstrael, A., & Duncker, D. (2022) · EP Europace · doi:10.1093/europace/euac137 · Cited by 4
Self-citationVeltmann, C., Bosch, R., Boer, J., Endres, M., Frankenstein, L., Gröschel, K., Hansen, C., & Straube, F. (2023) · Die Kardiologie · doi:10.1007/s12181-023-00634-z · Cited by 3
Indikationen Zur Loop-Rekorder-Implantation Bei Synkope
Schuchert, A. (2018) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-018-0571-1 · Cited by 2 · cited 1×
“Next to noninvasive monitoring strategies, implantable loop recorders (ILR) are used to confirm the etiology of syncope [2,12–18], with a shorter time to diagnosis, more frequent treat-ment initiation, and a positive impact on survival compared to a conventional diagnostic workup [13,17,19].”
MethodJilek, C., & Lewalter, T. (2020) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-020-00705-8 · Cited by 1 · cited 1×
“While international guidelines recommend ILR implantation in patients with unexplained recurrent syncope after a standard workup [5,22–24], implementation in daily clinical practice is lagging behind, partly due to reimbursement issues [25–30].”
BackgroundUnaufhaltsame Innovationen in der Elektrophysiologie
Bogossian, H., & Duncker, D. (2022) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-022-00842-2 · Cited by 1 · cited 1×
“Digital mobile or wearable devices are also increasingly used in the detection of arrhythmias [8–10].”
MethodSelf-citation
Cited by
Duvillier, L., Demolder, A., Renterghem, S. V., Mey, C. D., West, F., & Pooter, J. D. (2024) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16420 · Cited by 5
Vučković-Filipović, J., Irić-Ćupić, V., Davidović, G., et al. (2025) · medRxiv · doi:10.1101/2025.04.18.25326090 · Cited by 1
“…by a multicenter, cohort study from Greece that included 871 patients implanted with ILR due to presyncope, syncope, cryptogenic stroke, or palpitations (8), to 65%, as reported by an observational, retrospective study analyzing data on 1360 German ILR recipients with a diagnosis of syncope (22).”
Nuvvula, S., & Makaryus, A. N. (2025) · Expert Review of Medical Devices · doi:10.1080/17434440.2025.2514005
“ILRs can detect arrhythmias as a potential cause of syncope and have been shown to lead to a change in management [35].”
Vučković-Filipović, J., Ignjatović, V., Stanković, I., Ćićarić, N., Ignjatović, V., Davidović, G., Miloradović, V., Irić-Ćupić, V., Simić, I., & Djordjević, N. (2026) · Biomedicines · doi:10.3390/biomedicines14020466 · Cited by 1
“These findings are consistent with numerous cohort and registry data resultsconfirming the superior diagnostic yield of an ILR compared with conventional strategies [8,23].”
Haq, H., Gula, L., Moustafa, A. T., et al. (2026) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2026.06.030
Metadata
- Authors
- Mueller-Leisse, J., Hillmann, H. A. K., Iserloh, L., Fruehauf, B., & Duncker, D.
- Affiliations
- Hannover Heart Rhythm Center, Department of Cardiology and Angiology, Hannover Medical School, 30625 Hannover, Germany
- Medizinische Hochschule Hannover (DE)
- Medtronic (Germany) (DE)
- Corresponding author
- Duncker, David
- Venue
- Journal of Clinical Medicine
- Publisher
- MDPI AG
- Published
- 2024-03-08
- Volume
- 13
- Issue
- 6
- Pages
- 1564
- ISSN
- 2077-0383 (ISSN-L)
- PMC
- PMC10971208
- OpenAlex
- W4392601270
- Cited by
- 4
- References
- 44
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 1
- FWCI
- 1.12
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Journal of Clinical Medicine (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Medtronic
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Syncope and Autonomic Disorders
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Keywords
- implantable loop recorder, syncope, arrhythmia detection, diagnostic yield, antiarrhythmic therapy, pacemaker implantation, defibrillator implantation, ablation therapy, atrial fibrillation, anticoagulation, unexplained syncope
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
